Influência da Violência as Relações Afectivas de Jovens e a Prevenção do HIV\SIDA.

A violência social a que os jovens estão expostos hoje em dia, ultrapassou os campos da justiça, tornando-se um problema de saúde pública. Nos últimos anos, a cidade da Praia assistiu a uma elevação progressiva dos índices de criminalidade entre os jovens. Entretanto há que considerar-se que o jovem delinquente acaba por ser, ele mesmo, vítima desta violência. Por outro lado, há indicativos de tendência à juvenilização das doenças sexualmente transmissíveis em Cabo Verde, o que se constitui também em um problema de saúde pública. Considerando estes aspectos da realidade atual do pais, oobjectivo deste estudo é verificar se existeindícios de influência da violência social nas relações afectivas de jovens residentes nos bairros Eugénio Lima e Brasil na cidade de Praia, Cabo Verde.Para tanto realizou-se um estudo de caso nos citados bairrosnuma abordagem qualitativa, que utilizou para a coleta de dados realizada com24 jovens de 18 a 24 anos, umquestionário com enfoque sobre o estilo de vida, comportamento afetivo, experiência sexual e exposição à violência. Os resultados conseguidosnão apontaram indícios evidentes dainfluência da exposição à violência sobre as relações afetivas dos jovens e comportamentos de risco para o HIV/SIDA, apesar de revelarem uma percentagem elevada de comportamentos de risco desta infecção e uma exposição inequívoca e preocupante à violência nestes bairros.Todavia, abre precedentes para se fazer um estudo mais aprofundado, e apela também pela procura de causas em outros factores sociais e institucionais, como por exemplo, o uso precoce e exagerado de álcool e outras drogas, a submissão e a vulnerabilidade cultural e financeira da mulher, permitindo a sua passividade e “cumplicidade” em não usar o preservativo, a desvirtuação da informação sobre a soroprevalência pela possibilidade de subnotificação dos casos de VIH positivoe principalmente os modelos socioculturais em relação ao sexo.

Estudio Farmacogenético en Pacientes con Cáncer de Pulmón No Microcítico Avanzado tratados con Quimioterapia basada en Platino

a partir de ADN genómico obtenido de las células nucleadas de sangre periférica de 103 pacientes con Cáncer de Pulmón No Microcítico (CPNM) avanzado tratados con quimioterapia basada en platino, hemos analizado la asociación entre supervivencia y cinco SNPs (Single Nucleotide Polymorphism) pertenecientes a dos grupos de genes: i) de la via metabólica del ácido fólico (Timidilato Sintetasa (TS), Metil-tetrahidrofolato Reductasa (MTHFR) y, ii) de la vía de reparación del ADN (Excision repair cross-complemeting group 1 (ERCC1) y Xeroderma pigmentosum group D (XPD).

Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.

BACKGROUND: Prognosis prediction for resected primary colon cancer is based on the T-stage Node Metastasis (TNM) staging system. We investigated if four well-documented gene expression risk scores can improve patient stratification. METHODS: Microarray-based versions of risk-scores were applied to a large independent cohort of 688 stage II/III tumors from the PETACC-3 trial. Prognostic value for relapse-free survival (RFS), survival after relapse (SAR), and overall survival (OS) was assessed by regression analysis. To assess improvement over a reference, prognostic model was assessed with the area under curve (AUC) of receiver operating characteristic (ROC) curves. All statistical tests were two-sided, except the AUC increase. RESULTS: All four risk scores (RSs) showed a statistically significant association (single-test, P < .0167) with OS or RFS in univariate models, but with HRs below 1.38 per interquartile range. Three scores were predictors of shorter RFS, one of shorter SAR. Each RS could only marginally improve an RFS or OS model with the known factors T-stage, N-stage, and microsatellite instability (MSI) status (AUC gains < 0.025 units). The pairwise interscore discordance was never high (maximal Spearman correlation = 0.563) A combined score showed a trend to higher prognostic value and higher AUC increase for OS (HR = 1.74, 95% confidence interval [CI] = 1.44 to 2.10, P < .001, AUC from 0.6918 to 0.7321) and RFS (HR = 1.56, 95% CI = 1.33 to 1.84, P < .001, AUC from 0.6723 to 0.6945) than any single score. CONCLUSIONS: The four tested gene expression-based risk scores provide prognostic information but contribute only marginally to improving models based on established risk factors. A combination of the risk scores might provide more robust information. Predictors of RFS and SAR might need to be different.

Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells

Nanoparticles (NPs) are in clinical use or under development for therapeutic imaging and drug delivery. However, relatively little information exists concerning the uptake and transport of NPs across human colon cell layers, or their potential to invade three-dimensional models of human colon cells that better mimic the tissue structures of normal and tumoral colon. In order to gain such information, the interactions of biocompatible ultrasmall superparamagnetic iron oxide nanoparticles (USPIO NPs) (iron oxide core 9-10 nm) coated with either cationic polyvinylamine (aminoPVA) or anionic oleic acid with human HT-29 and Caco-2 colon cells was determined. The uptake of the cationic USPIO NPs was much higher than the uptake of the anionic USPIO NPs. The intracellular localization of aminoPVA USPIO NPs was confirmed in HT-29 cells by transmission electron microscopy that detected the iron oxide core. AminoPVA USPIO NPs invaded three-dimensional spheroids of both HT-29 and Caco-2 cells, whereas oleic acid-coated USPIO NPs could only invade Caco-2 spheroids. Neither cationic aminoPVA USPIO NPs nor anionic oleic acid-coated USPIO NPs were transported at detectable levels across the tight CacoReady? intestinal barrier model or the more permeable mucus-secreting CacoGoblet? model.

Promoção da adesão à prevenção do cancro da próstata. Intervenções de Enfermagem no centro de Saúde de Ribeira de Craquinha

O Cancro da Próstata é a neoplasia maligna que mais comummente afeta os homens em Cabo Verde, ocupando o terceiro lugar entre das causas de mortalidade por cancro entre os homens. Essa prevalência acompanha a tendência mundial de aumento das doenças crónicas não transmissíveis motivado pela adoção de estilos de vida não-saudáveis e por comportamentos de não procura de saúde. O aumento da incidência e da morbidade do cancro da próstata, sobretudo nos últimos anos, constitui um sério problema de saúde pública em Cabo Verde. Vários são os fatores que poderão estar por trás desses números, destacando-se de entre eles a resistência por parte dos homens em aderir à prevenção e à deteção precoce do cancro da próstata, quer por insuficiência de informações, quer por preconceitos presentes na nossa sociedade relacionados com a questão. O presente trabalho pretende abordar a problemática a jusante, isto é, pretende realçar a necessidade da enfermagem desenvolver estratégias para a promoção da adesão à prevenção, detetando precocemente o cancro da próstata. Por esta razão, este estudo propõe-se identificar os obstáculos que impedem os homens a aderir ao diagnóstico precoce do cancro da próstata na comunidade de Ribeira de Craquinha. A atuação da Enfermagem junto à comunidade na realização de trabalhos preventivos e promocionais de saúde torna-se imprescindível quando a questão é atingir os objetivos que permeiam os níveis de prevenção primária. Para alcançar o objetivo utilizou-se a metodologia qualitativa do tipo exploratório com uma abordagem fenomenológica utilizando como instrumento de recolha de dados a entrevista estruturada que foi aplicada a quatro (4) enfermeiros do centro da Ribeira de Craquinha. Os resultados evidenciaram que os profissionais de saúde devem dar mais atenção à saúde do homem e apostar mais nas estratégias para a consciencialização na prevenção do cancro da próstata. Também ao longo dos resultados constatamos que os homens por vergonha de expor o seu corpo aos profissionais de saúde, muito pouco procuram o sistema de saúde.

Factores pronósticos en el tratamiento adyuvante del cáncer de vejiga

El cáncer de vejiga es el cuarto tumor más frecuente en hombres. En este estudio se recogen 70 pacientes diagnosticados de carcinoma urotelial resecables en el Hospital Germans Trias y Pujol(1994 -2011). El objetivo es analizar que factores pronósticos determinan la realización del tratamiento adyuvante.La edad fue un factor pronóstico: menores de 70 años alcanzaban una mediana de supervivencia de 77 meses.Pacientes sin afectación ganglionar tenían una mediana de supervivencia de 77 meses frente a 26 meses (con afectación ganglionar)siendo significativo.La afectación linfovasular también evidenció peor supervivencia siendo significativa.En nuestra serie la quimioterapia adyuvante en cáncer de vejiga aporta un beneficio cuando existe afectación ganglionar y linfovascular.

Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.

The binding and penetration of two 125I-labeled anti-carcinoembryonic antigen (CEA) monoclonal antibodies (MAb) and their F(ab')2 and Fab fragments were measured in multicellular spheroids of poorly (HT29) and moderately well differentiated (Co112) human colon adenocarcinomas which express different amounts of CEA. Spheroids cultured in vitro model tumor microenvironments where poor vascular supply may modulate antigen expression and accessibility. The two MAb studied, 202 and 35, were shown previously to react with different CEA epitopes and to have high affinities of 1.2 and 5.8 X 10(9) M-1, respectively. MAb 202 has also been shown to cross-react with antigens present on human granulocytes and normal epithelial cells from human lung and pancreas. Specific binding of intact MAb and fragments of both antibodies was demonstrated for both types of human colon carcinoma spheroids compared to mouse colon carcinoma (CL26) and mammary tumor (EMT6/Ro) spheroids. Total binding of MAb and fragments was greater (1.5- to 2.5-fold) after 4 h compared to 1 h of exposure; the amount of binding compared to control IgG1 was 5- to 30-fold greater after 1-h incubation and 15 to 200 times greater after 4 h. This binding was stable as demonstrated by short and long wash experiments at 37 degrees and 4 degrees C. The binding of F(ab')2 and Fab fragments of the anti-CEA MAb 35 to spheroids of human colon Co112 was almost 2-fold greater than that of the intact MAb. However, for MAb 202, the binding of intact MAb and F(ab')2 was greater than that of Fab fragments. In addition the binding of both intact and F(ab')2 fragments of MAb 202 was greater than that obtained with MAb 35. Specific binding of both antibodies to HT29 spheroids, which express less CEA, was decreased for MAb and fragments of both 202 and 35. Autoradiography and immunoperoxidase experiments were performed to determine the penetration of MAb and fragments after incubation with intact spheroids. Comparisons were made with labeled MAb directly applied to frozen sections of spheroids. F(ab')2 and Fab fragments of both antibodies were bound at the surface of intact spheroids and penetrated to eight to ten cells, but the intact MAb were localized mainly at the spheroid surface and the outer one to three cell layers. There was much less binding at the surfaces of HT29 compared to Co112 spheroids. An enzyme immunoassay using MAb 35 and 202 demonstrated that Co112 spheroids produced about 8-fold more CEA/mg of cell protein than did monolayer cultures.(ABSTRACT TRUNCATED AT 400 WORDS)

Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features.

BACKGROUND: Differences exist between the proximal and distal colon in terms of developmental origin, exposure to patterning genes, environmental mutagens, and gut flora. Little is known on how these differences may affect mechanisms of tumorigenesis, side-specific therapy response or prognosis. We explored systematic differences in pathway activation and their clinical implications. MATERIALS AND METHODS: Detailed clinicopathological data for 3045 colon carcinoma patients enrolled in the PETACC3 adjuvant chemotherapy trial were available for analysis. A subset of 1404 samples had molecular data, including gene expression and DNA copy number profiles for 589 and 199 samples, respectively. In addition, 413 colon adenocarcinoma from TCGA collection were also analyzed. Tumor side-effect on anti-epidermal growth factor receptor (EGFR) therapy was assessed in a cohort of 325 metastatic patients. Outcome variables considered were relapse-free survival and survival after relapse (SAR). RESULTS: Proximal carcinomas were more often mucinous, microsatellite instable (MSI)-high, mutated in key tumorigenic pathways, expressed a B-Raf proto-oncogene, serine/threonine kinase (BRAF)-like and a serrated pathway signature, regardless of histological type. Distal carcinomas were more often chromosome instable and EGFR or human epidermal growth factor receptor 2 (HER2) amplified, and more frequently overexpressed epiregulin. While risk of relapse was not different per side, SAR was much poorer for proximal than for distal stage III carcinomas in a multivariable model including BRAF mutation status [N = 285; HR 1.95, 95% CI (1.6-2.4), P < 0.001]. Only patients with metastases from a distal carcinoma responded to anti-EGFR therapy, in line with the predictions of our pathway enrichment analysis. CONCLUSIONS: Colorectal carcinoma side is associated with differences in key molecular features, some immediately druggable, with important prognostic effects which are maintained in metastatic lesions. Although within side significant molecular heterogeneity remains, our findings justify stratification of patients by side for retrospective and prospective analyses of drug efficacy and prognosis.